Evidence map›Paper›PMID 36320552›Full record

ArticleJournal of multidisciplinary healthcare2022

The m7G Modification Level and Immune Infiltration Characteristics in Patients with COVID-19.

Lingling Lu, Jiaolong Zheng, Bang Liu, Haicong Wu, Jiaofeng Huang, Liqing Wu, Dongliang Li

Abstract read
In one paragraph

Article in Journal of multidisciplinary healthcare, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lingling Lu *Fuzong Clinical Medical College of Fujian Medical University, The 900th Hospital, Fuzhou, People's Republic of China.
Jiaolong Zheng *Fuzong Clinical Medical College of Fujian Medical University, The 900th Hospital, Fuzhou, People's Republic of China.
Bang Liu *Fuzong Clinical Medical College of Fujian Medical University, The 900th Hospital, Fuzhou, People's Republic of China.
Haicong WuFuzong Clinical Medical College of Fujian Medical University, The 900th Hospital, Fuzhou, People's Republic of China.
Jiaofeng HuangFuzong Clinical Medical College of Fujian Medical University, The 900th Hospital, Fuzhou, People's Republic of China.
Liqing WuDepartment of Hepatobiliary Disease, The 900th Hospital of Joint Logistics Support Force, Fuzhou, People's Republic of China.
Dongliang LiFuzong Clinical Medical College of Fujian Medical University, The 900th Hospital, Fuzhou, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The 7-methylguanosine (m7G)-related genes were used to identify the clinical severity and prognosis of patients with coronavirus disease 2019 (COVID-19) and to identify possible therapeutic targets. Patients and Methods: The GSE157103 dataset provides the transcriptional spectrum and clinical information required to analyze the expression of m7G-related genes and the disease subtypes. R language was applied for immune infiltration analysis, functional enrichment analysis, and nomogram model construction. Results: Most m7G-related genes were up-regulated in COVID-19 and were closely related to immune cell infiltration. Disease subtypes were grouped using a clustering algorithm. It was found that the m7G-cluster B was associated with higher immune infiltration, lower mechanical ventilation, lower intensive care unit (ICU) status, higher ventilator-free days, and lower m7G scores. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis showed that differentially expressed genes (DEGs) between m7G-cluster A and B were enriched in viral infection and immune-related aspects, including COVID-19 infection; Th17, Th1, and Th2 cell differentiation, and human T-cell leukemia virus 1 infection. Finally, through machine learning, six disease characteristic genes, NUDT4B, IFIT5, LARP1, EIF4E, LSM1, and NUDT4, were screened and used to develop a nomogram model to estimate disease risk. Conclusion: The expression of most m7G genes was higher in COVID-19 patients compared with that in non-COVID-19 patients. The m7G-cluster B showed higher immune infiltration and milder symptoms. The predictive nomogram based on the six m7G genes can be used to accurately assess risk.

Indexed as

7-methylguanosineCOVID-19immune cellsnomogramriskSARS-CoV-2

Identifiers

PMID36320552
PMCPMC9618243

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.